Press Releases

TORRANCE, Calif., July 8, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. ("Emmaus"), a leader in sickle cell disease treatment, announced today the screening of the first patient for the company's Pilot/Phase 1 study on the treatment of diverticulosis with pharmaceutical-grade L-glutamine ("PGLG"). The study will utilize the same PGLG oral powder used in En

NASHVILLE, Tenn., July 8, 2019 /PRNewswire/ -- Verdi Oncology, Inc., an oncology practice and clinical research management company, announced today it has partnered with Nashville Oncology Associates PC (NOA). The new partnership marks Verdi's entry into the state of Tennessee. Verdi focuses on partnering with community oncol

PHILADELPHIA, July 8, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Cediprof, Inc., a wholly owned subsidiary of privately held Neolpharma Pharmaceutical Group. 

NEW YORK, July 8, 2019 /PRNewswire/ -- Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce the promotion of Elizabeth Colonna to Vice President and the hiring of Jessie Laurash as Senior Associate. 

LAVAL, QC, July 8, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) announced today the appointment of Michael Cammarata, a successful entrepreneur and innovator in the wellness industry, as its Chief Executive Officer and Member of the Board of Directors effective today,

MORRISTOWN, N.J., July 8, 2019 /PRNewswire/ -- A 14-month-old female German shepherd puppy named Ondrea has been missing from Wantage, N.J. since the morning of June 24. Ondrea is nearly full-grown and weighs approximately 50 lbs.  She is identified with a tattoo in her right ear and a microchip. People

LAS VEGAS, July 8, 2019 /PRNewswire/ -- GNCC Capital, Inc. (OTC: GNCP) ("The Company" or "GNCC") is now in a position to address certain key issues and transactions, as follows:The Quarterly Report for the Nine Months Ended June 30, 2019 will be completed and filed tomorrow. We had expected to file prior to this Press Release bu

JERUSALEM, July 8, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) announced today that the first participants in the second cohort of the pivotal, clinical efficacy, Phase 3 trial of the M-001 universal flu vaccine candidate have been successfully enrolled.

TAIPEI, Taiwan, July 8, 2019 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce that it recently led and closed two investments, in Panther Orthopedics and Prodeon. Panther Orthopedics is a Silicon Valley startup company pioneering innovative dynamic fixation solut

NAPLES, Fla., July 8, 2019 /PRNewswire/ -- Evidence indicating human herpesvirus 6 (HHV-6) and related herpesviruses may contribute to the causation of Alzheimer's disease was presented in late June in a